Should GLP-1 agonists should be used earlier in type 2 diabetes? [profast acv keto gummies]

Should GLP-1 agonists should be used earlier in type 2 diabetes? [profast acv keto gummies]

| 1h 28m 28s | Video has closed captioning.

Video 2/3 in our series with Hannah Beba. In the future, GLP-1 agonists could be used early in treatment for type II diabetes and this could have an important impact on slowing the onset of complications, according to Hannah Beba, Consultant Pharmacist in Diabetes. Read more here - Register on our website for news straight to your inbox - Watch the full series on YouTube - Or our website - 0:00 - Will incretins be standard treatment? 2:13 - Oral GLP-1 agonists 5:27 - What people need to know about incretins This interview was recorded on 13/09/2023. ___ Keep up to date with us across our network; Email us at - [email protected] Site - Twitter - Instagram - Facebook - LinkedIn - This content is for informational purposes only, and does not replace the advice of your own doctor or healthcare professional. Copyright © 2022 MedicalUpdateOnline. IMI (a trading name of ICR UK Limited) is a digital communications agency that specialises in the pharmaceutical and medical industries. IMI was founded in 2003 by the current CEO Peter Mas-Mollinedo, a pharmacist and forward-thinking entrepreneur. IMI’s primary activities include the production of medical educational journals and bulletins, medical conference coverage and video interviewing of health care professionals worldwide to disseminate information such as trial results, new products, research, drug approvals, new accreditations, etc. It is a trusted provider of medical information to its extensive database of medical health care professionals in the UK, Europe and beyond. To find out more about IMI, please see our websites www.medicalupdateonline.com and www.medicalimi.com. Alternatively, you can email us at [email protected].